From the article:
“...The public health system is touting the infusion drug remdesivir, which requires hospitalization, also has side effects (like infections at the infusion site) and will cost hundreds of times the cost of two little pills taken at home for 5 days.
Maybe remdesivir’s huge income potential for the health system is relevant to this conversation. ...”
Good on the author of the article to unload on the cost of hydroxy + azithro vs. rwmdesivir !
I have nothing against Remdesivir. If it works, so much the better.
But we need to know its effectivity vs the less costly combo of HCQ + Azithromycin + Zinc and AT WHAT STAGE of the disease.
If Remdesivir is much more effective than the HCQ + Azithromycin + Zinc, by all means, let’s use it.
If the effectivity is equal or less than the combo, I don’t see why we should be favoring it over the combo.